Tumor myofibroblasts express CXCL13, and TGF-β induced by hypoxia drives the expression of CXCL13, leading to accelerated malignant progression and castration-resistant prostate cancer development [108] (see Figure 4). The gene discussed is CXCL13; the disease is prostate carcinoma.